American Capital Advisory’s Lam Research LRCX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$27.3K Buy
63
+12
+24% +$3.64K 0.01% 276
2026
Q1
$10.9K Buy
51
+5
+11% +$1.12K ﹤0.01% 335
2025
Q4
$7.88K Buy
46
+8
+21% +$1.24K ﹤0.01% 340
2025
Q3
$5.09K Buy
38
+2
+6% +$212 ﹤0.01% 356
2025
Q2
$3.5K Buy
+36
New +$2.85K ﹤0.01% 367
2024
Q3
Sell
-130
Closed -$10.2K 501
2024
Q2
$10.2K Hold
130
0.01% 258
2024
Q1
$6.89K Hold
130
0.01% 286
2023
Q4
$10.2K Buy
+130
New +$8.86K 0.01% 258

Other funds holding LRCX

American Capital Advisory's LRCX Position: Q2 2026 in Review

American Capital Advisory increased its Lam Research (LRCX) stake by 24% in Q2 2026, buying an estimated $3.64K and bringing the position to 63 shares worth $27.3K. The position accounts for 0.01% of the portfolio, ranked #276.

American Capital Advisory first reported a position in LRCX in Q4 2023 and has held it in 8 quarters since. 3,135 funds tracked by Wall St. Rank hold LRCX as of Q2 2026.

  • American Capital Advisory held 63 shares of Lam Research worth $27.3K as of Q2 2026.
  • American Capital Advisory bought 12 Lam Research shares in Q2 2026, an estimated $3.64K.
  • Lam Research made up 0.01% of American Capital Advisory's portfolio in Q2 2026, its #276 holding.
  • American Capital Advisory first reported a position in Lam Research in Q4 2023 and has held it in 8 quarters since.
  • 3,135 funds tracked by Wall St. Rank held Lam Research as of Q2 2026.

Based on American Capital Advisory's 13F filing for Q2 2026, filed 28 Jul 2026.